Publicacions (202) Publicacions de MARIA JOSE ALCARAZ TORMO

filter_list

2024

  1. Control of articular degeneration by extracellular vesicles from stem/stromal cells as a potential strategy for the treatment of osteoarthritis

    Biochemical Pharmacology, Vol. 228

  2. Hyaluronic Acid Hampers the Inflammatory Response Elicited by Extracellular Vesicles from Activated Monocytes in Human Chondrocytes

    Pharmaceutics, Vol. 16, Núm. 11

  3. Osteostatin Mitigates Gouty Arthritis through the Inhibition of Caspase-1 Activation and Upregulation of Nrf2 Expression

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

2022

  1. Cellular and Molecular Targets of Extracellular Vesicles from Mesenchymal Stem/Stromal Cells in Rheumatoid Arthritis

    Stem cells translational medicine, Vol. 11, Núm. 12, pp. 1177-1185

  2. Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1

    International journal of molecular sciences, Vol. 23, Núm. 15

2021

  1. Evaluation of Extracellular Vesicles from Adipose Tissue-Derived Mesenchymal Stem Cells in Primary Human Chondrocytes from Patients with Osteoarthritis

    Methods in Molecular Biology (Humana Press Inc.), pp. 221-231

  2. Extracellular vesicles do not mediate the anti-inflammatory actions of mouse-derived adipose tissue mesenchymal stem cells secretome

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-14

  3. New potential therapeutic approaches targeting synovial fibroblasts in rheumatoid arthritis

    Biochemical Pharmacology, Vol. 194

  4. Role of peroxiredoxin 6 in the chondroprotective effects of microvesicles from human adipose tissue-derived mesenchymal stem cells

    Journal of Orthopaedic Translation, Vol. 30, pp. 61-69

2020

  1. Extracellular vesicles from mesenchymal stem cells as novel treatments for musculoskeletal diseases

    Cells, Vol. 9, Núm. 1

  2. Pharmacological modulation of redox signaling pathways in disease

    Free Radical Biology and Medicine

  3. Relevance of Nrf2 and heme oxygenase-1 in articular diseases

    Free Radical Biology and Medicine, Vol. 157, pp. 83-93

2019

  1. Emerging therapeutic agents in osteoarthritis

    Biochemical Pharmacology, Vol. 165, pp. 4-16

  2. Extracellular Vesicles from Mesenchymal Stem Cells as Novel Treatments for Musculoskeletal Diseases

    Cells, Vol. 9, Núm. 1

  3. Osteostatin inhibits collagen-induced arthritis by regulation of immune activation, pro-inflammatory cytokines, and osteoclastogenesis

    International Journal of Molecular Sciences, Vol. 20, Núm. 16

2018

  1. Extracellular vesicles: A new therapeutic strategy for joint conditions

    Biochemical Pharmacology, Vol. 153, pp. 134-146

  2. Fármacos antireumáticos y antigotosos

    Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 519-530

  3. Microvesicles from Human Adipose Tissue-Derived Mesenchymal Stem Cells as a New Protective Strategy in Osteoarthritic Chondrocytes

    Cellular Physiology and Biochemistry, Vol. 47, Núm. 1, pp. 11-25

  4. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

    Journal of Extracellular Vesicles, Vol. 7, Núm. 1

  5. Myeloid heme oxygenase-1 regulates the acute inflammatory response to zymosan in the mouse air pouch

    Oxidative Medicine and Cellular Longevity, Vol. 2018